Related Experiment Video
Updated: Mar 5, 2026

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis
Published on: February 24, 2023
Gastrointestinal manifestations of melioidosis: A single center experience
Nitin Jagtap1, Harshal Shah2, Anuradha Kancharla2
1Department of Gastroenterology, Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad, 500 082, India. docnits13@gmail.com.
Abstract:
Melioidosis, being increasing, is reported from India. Gastrointestinal manifestations are typically reported as unusual cause of liver and/or splenic abscess. We aimed to describe various gastrointestinal manifestation of melioidosis in the present study. We retrospectively collected data of culture positive melioidosis cases from hospital database during August 2014-October 2016 at Asian Institute of Gastroenterology, Hyderabad. A total of nine culture positive cases (8 male) of melioidosis with median age of 40 years (range 23-66) were analyzed. Median duration of symptoms was 45 days. Two patients were being treated as tuberculosis. Three patients presented with liver abscess with two of them having simultaneous splenic abscess, and one had prostatic abscess. Three patients (43%) with history of acute pancreatitis had infected pancreatic collection, and one patient had left empyema with splenic abscess. One patient had wound infection with left lower limb cellulitis, presented as acute in chronic liver failure and another as spontaneous bacterial peritonitis (SBP). Diabetes and/or alcoholism was present in all patients. Seven patients had disseminated organ involvement. Seven patients underwent percutaneous intervention for drainage of abscess. Induction therapy as ceftazidime (n=4) or meropenem (n=5) followed by continuation therapy as oral cotrimoxazole (n=6) and doxycycline (n=1) was given. Six patients completed therapy and asymptomatic at end of follow up. Two patients died in the study period. One patient died due to acute-on-chronic liver failure (ACLF) with acute kidney injury and the other due to cardiac failure. One patient with SBP had lost to follow up. Apart from being unusual cause of liver/splenic abscess, melioidosis can present with infection of pancreatic collection, SBP, and infection in a compensated cirrhosis which can precipitate ACLF. Early recognition and specific therapy can improve prognosis.
Insights
Melioidosis, a growing concern in India, often presents unusually with gastrointestinal issues like liver and splenic abscesses. Early diagnosis and treatment are crucial for better outcomes in these complex cases.
Area of Science:
- Infectious Diseases
- Gastroenterology
- Hepatology
Background:
- Melioidosis is an emerging infectious disease in India, frequently presenting with atypical manifestations.
- Gastrointestinal involvement in melioidosis is often overlooked, typically presenting as liver and/or splenic abscesses.
Purpose of the Study:
- To investigate and describe the diverse gastrointestinal manifestations of melioidosis.
- To highlight the importance of recognizing melioidosis in patients with unexplained abscesses and gastrointestinal symptoms.
Main Methods:
- Retrospective analysis of culture-positive melioidosis cases from August 2014 to October 2016.
- Data collection included patient demographics, clinical presentation, diagnostic methods, treatment, and outcomes.
Main Results:
- Nine culture-positive melioidosis cases (8 males, median age 40) were analyzed, with a median symptom duration of 45 days.
- Common presentations included liver abscess (3), splenic abscess (2), infected pancreatic collection (3), and spontaneous bacterial peritonitis (1).
- All patients had diabetes and/or alcoholism; seven had disseminated organ involvement and underwent percutaneous drainage.
Conclusions:
- Melioidosis can manifest with unusual gastrointestinal complications, including pancreatic collections, spontaneous bacterial peritonitis, and precipitating acute-on-chronic liver failure in patients with cirrhosis.
- Prompt recognition and specific antimicrobial therapy, such as ceftazidime or meropenem followed by cotrimoxazole, are vital for improving prognosis and reducing mortality.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Other Disorders of Digestive System
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

